189 related articles for article (PubMed ID: 22374428)
1. Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis.
Sonnenblick A; Shriki A; Galun E; Axelrod JH; Daum H; Rottenberg Y; Hamburger T; Mali B; Peretz T
Clin Transl Oncol; 2012 Mar; 14(3):232-6. PubMed ID: 22374428
[TBL] [Abstract][Full Text] [Related]
2. Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer.
Sonnenblick A; Uziely B; Nechushtan H; Kadouri L; Galun E; Axelrod JH; Katz D; Daum H; Hamburger T; Maly B; Allweis TM; Peretz T
Breast Cancer Res Treat; 2013 Apr; 138(2):407-13. PubMed ID: 23446809
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL
Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423
[TBL] [Abstract][Full Text] [Related]
4. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C; Zhou S; Ke CS; Li NP; Wu RL
Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.
Aleskandarany MA; Agarwal D; Negm OH; Ball G; Elmouna A; Ashankyty I; Nuglozeh E; Fazaludeen MF; Diez-Rodriguez M; Nolan CC; Tighe PJ; Green AR; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Feb; 156(1):9-20. PubMed ID: 26907764
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of potential Stat3-regulated genes in human breast cancer.
Hsieh FC; Cheng G; Lin J
Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048
[TBL] [Abstract][Full Text] [Related]
7. p-STAT3 expression in breast cancer correlates negatively with tumor size and HER2 status.
Wang Y; Wang Q; Tang CH; Chen HD; Hu GN; Shao JK; Dong XF; Jin LL; Wang CQ
Medicine (Baltimore); 2021 Mar; 100(10):e25124. PubMed ID: 33725911
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma.
Min H; Wei-hong Z
J Obstet Gynaecol Res; 2009 Oct; 35(5):918-25. PubMed ID: 20149042
[TBL] [Abstract][Full Text] [Related]
10. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
Falck AK; Fernö M; Bendahl PO; Rydén L
World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
[TBL] [Abstract][Full Text] [Related]
11. Expression of signal transducer and activator of transcription 3 in breast cancer and its clinical significance.
Wei G; Mingliang Z; Yong C; Suyang G
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C56-8. PubMed ID: 26323925
[TBL] [Abstract][Full Text] [Related]
12. Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer.
Thor AD; Liu S; Edgerton S; Moore D; Kasowitz KM; Benz CC; Stern DF; DiGiovanna MP
J Clin Oncol; 2000 Sep; 18(18):3230-9. PubMed ID: 10986055
[TBL] [Abstract][Full Text] [Related]
13. Signal transducer and activator of transcription 3 overexpression promotes lymph node micrometastasis in early-stage non-small cell lung cancer.
Yu Y; Zhao Q; He XP; Wang Z; Liu XY; Zhang ZP
Thorac Cancer; 2018 May; 9(5):516-522. PubMed ID: 29575778
[TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
Nevalainen MT; Xie J; Torhorst J; Bubendorf L; Haas P; Kononen J; Sauter G; Rui H
J Clin Oncol; 2004 Jun; 22(11):2053-60. PubMed ID: 15169792
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer.
Horita K; Yamaguchi A; Hirose K; Ishida M; Noriki S; Imamura Y; Fukuda M
Eur J Histochem; 2001; 45(1):73-84. PubMed ID: 11411868
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation in breast cancer is a major determinant of clinical outcome in node-positive but not in node-negative patients.
Treré D; Ceccarelli C; Migaldi M; Santini D; Taffurelli M; Tosti E; Chieco P; Derenzini M
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):314-23. PubMed ID: 16932023
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer.
Su F; Ren F; Rong Y; Wang Y; Geng Y; Wang Y; Feng M; Ju Y; Li Y; Zhao ZJ; Meng K; Chang Z
Breast Cancer Res; 2012 Mar; 14(2):R38. PubMed ID: 22394684
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.
Mitra D; Bhattacharyya S; Alam N; Sen S; Mitra S; Mandal S; Vignesh S; Majumder B; Murmu N
Breast Cancer Res Treat; 2020 Jan; 179(2):359-370. PubMed ID: 31686261
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
Xu YH; Lu S
Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
[TBL] [Abstract][Full Text] [Related]
20. STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer.
Deng JY; Sun D; Liu XY; Pan Y; Liang H
World J Gastroenterol; 2010 Nov; 16(42):5380-7. PubMed ID: 21072904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
